Localized sclerostin accumulation in osteocyte lacunar-canalicular system is associated with cortical bone microstructural alterations and bone fragility in db/db male mice

Bone fragility in type 2 diabetes mellitus (T2DM) is often characterized by impaired bone quality, despite normal or increased bone mineral density. Serum sclerostin levels are elevated in diabetes, yet its role in bone fragility is not fully understood. Sclerostin (SOST) is a Wnt signaling inhibito...

Full description

Bibliographic Details
Published in:	Frontiers in Cell and Developmental Biology
Main Authors:	Xingfan Wu, Yuanli Ai, Yutao He, Dan Ma, Xi Li, Xiao Huang, Rui Cheng, Bin Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Subjects:	sclerostin lacunar-canalicular system diabetes bone fragility localized accumulation
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2025.1562764/full

Similar Items

A Potential Participant in Type 2 Diabetes Bone Fragility: TIMP-1 at Sites of Osteocyte Lacunar-Canalicular System
by: Pei Q, et al.
Published: (2021-12-01)

Role of the osteocyte in bone metastasis – The importance of networking
by: Stefaan W. Verbruggen
Published: (2024-02-01)

Outcomes of canalicular trephination versus canaliculodacryocystorhinostomy in common canalicular blocks
by: Tejaswini Vukkadala, et al.
Published: (2022-01-01)

Immune escape of Staphylococcus aureus mediated by osteocyte lacuna-canalicular network leads to persistent and uncured bone infection
by: Zhigang Rong, et al.
Published: (2025-06-01)

Spatial heterogeneity in the canalicular density of the osteocyte network in human osteons
by: Felix Repp, et al.
Published: (2017-06-01)

Long-Term Results of Mini-Monoka® Monocanalicular Intubation in the Repair of Canalicular Lacerations
by: Armida L. Suller, MD, et al.
Published: (2018-06-01)

A novel optimized silver nitrate staining method for visualizing the osteocyte lacuno-canalicular system
by: Jinlian Wu, et al.
Published: (2025-05-01)

IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages
by: Zengxin Jiang, et al.
Published: (2023-03-01)

Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectives
by: Tao Xiaohui, et al.
Published: (2024-07-01)

Role of sclerostin in mastocytosis bone disease
by: Aneta Szudy-Szczyrek, et al.
Published: (2025-01-01)

Punctal and Canalicular Obstruction Associated with Dyskeratosis Congenita
by: Taner Kar, et al.
Published: (2015-01-01)

Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice
by: Wen Liu, et al.
Published: (2019-05-01)

Canaliculotomy as A Canalicular Obstruction Management Approach: a Case Series
by: Raden Angga Kartiwa, et al.
Published: (2022-09-01)

Association of total and bioactive serum sclerostin levels with bone metabolism in type 2 diabetes mellitus
by: Cyril Traechslin, et al.
Published: (2025-06-01)

Is sclerostin antibody an effective agent for alveolar bone regeneration in animal models? A scoping review
by: Venkitachalam Ramanarayanan, et al.
Published: (2022-12-01)

Elevated Circulating Sclerostin Levels in Frail Older Adults: Implications beyond Bone Health
by: Ji Yeon Baek, et al.
Published: (2025-02-01)

Infartos lacunares
by: Jorge Tapia I, et al.
Published: (2017-09-01)

The Role of Osteocytes in Inflammatory Bone Loss
by: Corinne E. Metzger, et al.
Published: (2019-05-01)

Sclerostin's role in bone–muscle crosstalk and osteoporosis pathogenesis
by: Hamzah Shahid, et al.
Published: (2025-09-01)

Identification of Sclerostin as a Putative New Myokine Involved in the Muscle-to-Bone Crosstalk
by: Maria Sara Magarò, et al.
Published: (2021-01-01)

Lipid Nanoparticle Delivery of siRNA to Osteocytes Leads to Effective Silencing of SOST and Inhibition of Sclerostin In Vivo
by: Genc Basha, et al.
Published: (2016-01-01)

Sclerostin antibody promotes alveolar bone regeneration after tooth extraction
by: Erdal Ergünol, et al.
Published: (2025-10-01)

Management of bi-canalicular block: A novel technique
by: Manju Meena, et al.
Published: (2013-01-01)

Effects of anti-sclerostin antibody and running on bone remodeling and strength
by: H. Toumi, et al.
Published: (2015-06-01)

Clinical Features of Patients with Post-Traumatic Canalicular Laceration and the Effectiveness of Surgical Repair with Monoka Tube Intubation
by: Özlem Kuru, et al.
Published: (2015-01-01)

Sclerostin as a novel marker of bone turnover in athletes
by: A Zagrodna, et al.
Published: (2016-02-01)

Fractal dimension and lacunarity analysis of mandibular bone on digital panoramic radiographs of tobacco users
by: Suman Basavarajappa, et al.
Published: (2021-05-01)

Canalicular adenoma of the hard palate: A rare case report
by: Milad Khodaei, et al.
Published: (2021-01-01)

Recombinant sclerostin inhibits bone formation in vitro and in a mouse model of sclerosteosis
by: Timothy Dreyer, et al.
Published: (2021-07-01)

Detailing the influence of PEO-coated biodegradable Mg-based implants on the lacuno-canalicular network in sheep bone: A pilot study
by: Jonathan Espiritu, et al.
Published: (2023-08-01)

Sost Deficiency does not Alter Bone’s Lacunar or Vascular Porosity in Mice
by: Henry Mosey, et al.
Published: (2017-09-01)

Osteoclast and Sclerostin Expression in Osteocytes in the Femoral Head with Risedronate Therapy in Patients with Hip Fractures: A Retrospective Comparative Study
by: Hwan-Hee Lee, et al.
Published: (2022-10-01)

Mature primary human osteocytes in mini organotypic cultures secrete FGF23 and PTH1-34-regulated sclerostin
by: Helen J. Knowles, et al.
Published: (2023-05-01)

Minimonoka Stent for Canalicular Reconstruction
by: Sunil G Biradar,, et al.
Published: (2015-04-01)

Serum Sclerostin Level Is Negatively Associated with Bone Mineral Density in Hemodialysis Patients
by: Jing-Wun Lu, et al.
Published: (2022-03-01)

Anti-sclerostin antibody – A potential therapeutic target for periodontal bone regeneration
by: Shruthi Reghunath, et al.
Published: (2024-07-01)

Canalicular Adenoma with Unicystic Morphology—A Rare Case Report
by: Deepthi Beena, et al.
Published: (2025-01-01)

CM2 antigen, a potential novel molecule participating in glucuronide transport on rat hepatocyte canalicular membrane
by: L. Wang, et al.
Published: (2012-06-01)

Influence of Muscle Mass and Strength on Bone Mineralisation with Consideration of Sclerostin Concentration
by: Martyna Patalong-Wójcik, et al.
Published: (2023-05-01)

Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein
by: Nicole R Gould, et al.
Published: (2021-03-01)